[PSA] external review is not what most of this community thinks it is
Putting this at the top of the board where it belongs: external review is not what most of this community thinks it is.
Internal appeals are decided by the plan. External review is decided by an independent body and, where it applies, its determination is binding. They are separate mechanisms and the second is chronically underused.
Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.
A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.
That is everything I have. The rest is opinion and I have tried to keep it out.
best — the order this archive was captured in
Why step therapy denials feel unfair and are nonetheless beatable.
The requirement is that documented trials of preferred alternatives exist. It is a record-keeping standard, not a clinical judgement about you, which is why arguing the clinical merits rarely moves it and producing dates and durations often does.
What to assemble: what was tried, at what dose, for how long, and what the documented outcome was. A one-page table with dates beats three pages of prose every time. Where a trial is contraindicated rather than simply unsuccessful, that needs to be stated explicitly by the prescriber in those terms.
None of this is legal or medical advice — it is what the threads here have found works.
Why step therapy denials feel unfair and are nonetheless beatable.
Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.
Yes. Written, always, even when they tell you a phone call is sufficient.
Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.
document what has been tried and for how long, that is the whole case
New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.
Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.
Small fix — external review is independent of the plan. The second-level internal appeal is not.
A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.
prior authorisation criteria change every plan year
That criterion is from the previous plan year. The current bulletin has different wording.
This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.
Not convinced. That is a formulary exclusion rather than a prior authorisation denial, and the route to challenge it is different.
Is this a prior authorisation denial or a formulary exclusion?
Employer plan or individual plan?
a template letter that quotes their own criteria back is the strongest one
ask for the clinical policy bulletin by number
the formulary is published, read it before you appeal